Literature DB >> 9125209

Oxidative stress is found in amyloid deposits in systemic amyloidosis.

Y Ando1, N Nyhlin, O Suhr, G Holmgren, K Uchida, M el Sahly, T Yamashita, H Terasaki, M Nakamura, M Uchino, M Ando.   

Abstract

Oxidative stress in human amyloid deposits from patients with systemic amyloidosis, such as familial amyloidotic polyneuropathy (FAP), primary amyloidosis, and secondary amyloidosis, was examined immunohistochemically by means of an affinity purified anti-hydroxynonenal (HNE) antibody to HNE, a marker of lipid peroxidation. Furthermore, the levels of thiobarbituric acid reactive substances (TBARS), which is another marker of lipid peroxidation, and the levels of protein carbonyl, a maker of protein modifications by free radicals, were determined in FAP patients and healthy controls. Affinity purified anti-HNE antibody reacted with amyloid deposits in all types of amyloid tissues examined. Significantly higher levels of TBARS and protein carbonyl were found in amyloid rich tissues of FAP patients compared with those in the control subjects. These results verify that lipid peroxidation via free radical injury occurs in amyloid deposits in systemic amyloidosis. The protein modifying properties of free radicals increase the likelihood that they play an important role in the amyloid formation process.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9125209     DOI: 10.1006/bbrc.1996.5997

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  24 in total

1.  Age-related oxidative modifications of transthyretin modulate its amyloidogenicity.

Authors:  Lei Zhao; Joel N Buxbaum; Natàlia Reixach
Journal:  Biochemistry       Date:  2013-03-04       Impact factor: 3.162

2.  Morphologic assessment of oxidative damage: A review.

Authors:  T D Oberley; T A Zainal
Journal:  J Am Aging Assoc       Date:  2000-01

Review 3.  4-Hydroxy-nonenal-A Bioactive Lipid Peroxidation Product.

Authors:  Rudolf J Schaur; Werner Siems; Nikolaus Bresgen; Peter M Eckl
Journal:  Biomolecules       Date:  2015-09-30

Review 4.  Liver transplantation and new therapeutic approaches for familial amyloidotic polyneuropathy (FAP).

Authors:  Yukio Ando
Journal:  Med Mol Morphol       Date:  2005-09       Impact factor: 2.309

5.  Systemic and microvascular oxidative stress induced by light chain amyloidosis.

Authors:  Raymond Q Migrino; Parameswaran Hari; David D Gutterman; Megan Bright; Seth Truran; Brittany Schlundt; Shane A Phillips
Journal:  Int J Cardiol       Date:  2009-05-15       Impact factor: 4.164

6.  A possible role for miRNA silencing in disease phenotype variation in Swedish transthyretin V30M carriers.

Authors:  Malin Olsson; Nina Norgren; Konen Obayashi; Violaine Plante-Bordeneuve; Ole B Suhr; Kristina Cederquist; Jenni Jonasson
Journal:  BMC Med Genet       Date:  2010-09-14       Impact factor: 2.103

7.  Specific pathogen free conditions prevent transthyretin amyloidosis in mouse models.

Authors:  Seiya Inoue; Mika Ohta; Zhenghua Li; Gang Zhao; Yutaka Takaoka; Naomi Sakashita; Kazuhisa Miyakawa; Koji Takada; Hajime Tei; Misao Suzuki; Michio Masuoka; Yoshiyuki Sakaki; Kiyoshi Takahashi; Ken-Ichi Yamamura
Journal:  Transgenic Res       Date:  2008-03-21       Impact factor: 2.788

8.  Heterogeneity of penetrance in familial amyloid polyneuropathy, ATTR Val30Met, in the Swedish population.

Authors:  Urban Hellman; Flora Alarcon; Hans-Erik Lundgren; Ole B Suhr; Catherine Bonaiti-Pellié; Violaine Planté-Bordeneuve
Journal:  Amyloid       Date:  2008-09       Impact factor: 7.141

9.  Light chain amyloidosis - current findings and future prospects.

Authors:  Elizabeth M Baden; Laura A Sikkink; Marina Ramirez-Alvarado
Journal:  Curr Protein Pept Sci       Date:  2009-10       Impact factor: 3.272

10.  Prognostic implication of late gadolinium enhancement on cardiac MRI in light chain (AL) amyloidosis on long term follow up.

Authors:  Raymond Q Migrino; Richard Christenson; Aniko Szabo; Megan Bright; Seth Truran; Parameswaran Hari
Journal:  BMC Med Phys       Date:  2009-05-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.